sab63090
1 minute ago
Investor:
My thought on this is that approval for a large population (96.8% whites) will pass along with some sort of ongoing trial, the key benefits are from a simpler delivery of the drug (no infusions, Ct-scans, travel, etc)...
the main thing: World Wide Health Care Costs